The Effect of IV NSAID's and Corticosteroids on Dysphasia and Dysphonia Following ASDF

Phase 3

Terminated

• Conditions: Dysphagia; Dysphonia

• Registration Number: NCT04650893
• Lead Sponsor: University of Nebraska

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-11-12
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Terminated
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion Criteria:<br><br> - 19 years of age and older<br><br> - Undergoing anterior cervical discectomy and fusion (ACDF) for radiculopathy or<br> myelopathy<br><br> - No known allergies or sensitivities to steroid or non-steroidal medications<br><br>Exclusion Criteria:<br><br> - Procedure is being done for revision, trauma, infection or tumor<br><br> - Patients with known diagnosed metabolic diseases (diabetes, pancreatitis, gout,<br> electrolyte imbalances, hypertension, hematological abnormalities including<br> gastrointestinal bleeding...)<br><br> - Patients with known kidney disease or a creatinine level above the upper limit of<br> normal >1.27

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of Patients With Moderate/Severe Bazaz Classification;Percentage of Patients With Severe Dysphagia Based on the Eating Assessment Tool (EAT-10)

Secondary Outcome Measures

Name	Time	Method
Percentage of Patients With Clinically Significant Voice Handicap Index-10 (VHI-10).;Mean Neck Disability Index (NDI)